Phenomenology of Racing and Crowded Thoughts in Mood Disorders: a Theoretical Reappraisal
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Chapter 7 Mood Disorders
An Overview of Mood Disorders • Gross Deviations in Mood • 2 Fundamental states: Depression & Mania Chapter 7 • Depression: “The Low” – Major Depressive Episode •The most commonly diagnosed & most severe Mood Disorders depression •Depressed (or in children, irritable) mood state that lasts at least 2 weeks –Cognitive symptoms •Feelings of worthlessness or inappropriate guilt •Diminished ability to concentrate or indecisiveness – Dysthymic Disorder –Disturbed physical functions (vegetative •Similar symptoms to Major Depressive Episode, symptoms) (central to the disorder) but milder •Insomnia or hypersomnia nearly every day –Also fewer symptoms: need only 2 of the •Significant weight loss or gain or change in symptoms, as opposed to 5 in Major Depressive appetite Episode •Fatigue or loss of energy nearly every day •A persistently depressed (or, in children & •Psychomotor agitation or retardation adolescents, irritable) mood that continues for at –Nearly always accompanied by markedly least 2 years diminished interest or ability to experience pleasure –During those 2 years, the individual has never been (anhedonia) from life without the symptoms for more than 2 months at a • Average duration if untreated: 9 months time •Most people with Dysthymia eventually experience a major depressive episode • Mania: “The High” –Abnormally exaggerated elation, joy, or euphoria OR irritability (common toward the –Behavioral symptoms end of the episode) lasting at least 1 week •More talkative / pressured speech –Cognitive symptoms •Psychomotor agitation -
Life with Bipolar Fact Sheet.Pdf
Being so scared Having so Trying to You do not Exhilarating. You you’remisunderstood paralyzed much energy catch up to want the finally feel like that you stress your own high of the you’re normal, out your mind mind mania to until the anger and your body end; then sets in An amazing after the feeling that high of the leads to feeling Things are mania is horrible going You have no over, the Difficult to tell if great and inhibitions, and lows set in you can trust your it’s scary consequences and reality own perception because don’t apply to becomes a of reality You feel you know what you do problem everything at it will not once and then stay that you are numb way to the world Being on a see-saw Flipping a The of human emotion switch in future your mind “Normal” quickly people are goes Mania is speed. from annoying You must start and Being constantly in bright because finish everything activities that take up to you’ll never Productive, now—you can’t time with hardly any carefree, bleak have that stop moving results or satisfation and then stability exhausting Busy brain, When the mania busy Unending back burns out, you’ve senses, and forth with got nothing left Frightening to be so out of busy libido yourself in you control and off-balance Share what life with bipolar disorder feels like for you in words, images or video by tagging your social media posts with #mentalillnessfeelslike. Posts will be displayed at mentalhealthamerica.net/feelslike where you can also submit anonymously if you choose. -
Delirium & Delirious Mania
Delirium & Delirious Mania; Differential Diagnosis. Delirium & Delirious Mania; Differential Diagnosis. Author: Eline Janszen. (s894226) Thesis-Supervisor: Ruth Mark Bachelorthesis Clinical Health Psychology Department of Neuropsychology, University of Tilburg September, 2011. 1 Delirium & Delirious Mania; Differential Diagnosis. ABSTRACT In the last few years, delirium in hospitals and in the elderly population has become an important subject of various studies, resulting in the recognition of several subtypes; hyperactive delirium, hypoactive delirium and mixed delirium. The first one of these subtypes, hyperactive delirium, shows a lot of overlap with another syndrome: Delirious mania. The current literature review examines both syndromes, discussing the overlap and the differences of their symptoms, while also looking at the neurological structures involved. Search engines including Sciencedirect, PSYCHinfo and medline were used to find the relevant literature. The data found in this examination reveals that, in spite of the several overlapping symptoms, delirious mania and hyperactive delirium are different syndromes; hyperactive delirium is associated with symptoms like hyperactivity, circardian rhythm disturbances and neurological abnormalities that include lesions of the hippocampus and dysfunction of the orbitofrontal cortex while delirious mania shows distinctive symptoms like pouring water and denudativeness (disrobing) with neurological abnormalities that also include orbitofrontal cortex dysfunction, but suffer mostly from an overall frontal circuitry dysfunction. This distinction is important for clinical outcome, seeing as that hyperactive delirium is treated with haloperidol and the preferred treatment for delirious mania is ECT. Keywords: delirium, hyperactive delirium, delirious mania. 2 Delirium & Delirious Mania; Differential Diagnosis. INTRODUCTION In recent years there has been a lot of research focused on diagnosing delirium. Since patients with delirium display fluctuating symptoms, the distinction from other conditions can be difficult. -
New Zealand Data Sheet
New Zealand Data sheet 1 ABILIFYTM TABLETS AbilifyTM 5 mg, 10 mg, 15 mg, 20 mg & 30 mg tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Aripiprazole. Each tablet contains 5 mg, 10 mg, 15 mg, 20 mg or 30 mg of aripiprazole. Excipient with known effect: Lactose monohydrate For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Abilify (aripiprazole) is available as: 5 mg blue, modified rectangular, shallow convex, bevel-edged, tablets, marked on one side with “A-007” and “5”; 10 mg pink, modified rectangular, shallow convex, bevel-edged, tablets, marked on one side with “A-008” and “10”; 15 mg yellow, round, shallow convex, bevel-edged, tablets, marked on one side with “A-009” and “15”; 20 mg white to pale yellowish white, round, shallow convex, bevel-edged, tablets, marked on one side with “A-010” and “20”; 30 mg pink, round, shallow convex, bevel-edged, tablets, marked on one side with “A-011” and “30”. 4 CLINICAL PARTICULARS 4.1 Therapeutic indications Abilify is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy. Abilify monotherapy is indicated for acute and maintenance treatment of manic and mixed episodes with Bipolar I Disorder with or without psychotic features. Abilify is indicated as an adjunctive therapy to either lithium or valproate for the acute treatment of manic and mixed episodes associated with Bipolar I Disorder with or without psychotic features. 4.2 Dose and method of administration Recommended Dosage Schizophrenia Adults The recommended starting dose for Abilify is 10 or 15 mg/day administered on a once-a-day schedule without regard to meals. -
Children's Mental Health Disorder Fact Sheet for the Classroom
1 Children’s Mental Health Disorder Fact Sheet for the Classroom1 Disorder Symptoms or Behaviors About the Disorder Educational Implications Instructional Strategies and Classroom Accommodations Anxiety Frequent Absences All children feel anxious at times. Many feel stress, for example, when Students are easily frustrated and may Allow students to contract a flexible deadline for Refusal to join in social activities separated from parents; others fear the dark. Some though suffer enough have difficulty completing work. They worrisome assignments. Isolating behavior to interfere with their daily activities. Anxious students may lose friends may suffer from perfectionism and take Have the student check with the teacher or have the teacher Many physical complaints and be left out of social activities. Because they are quiet and compliant, much longer to complete work. Or they check with the student to make sure that assignments have Excessive worry about homework/grades the signs are often missed. They commonly experience academic failure may simply refuse to begin out of fear been written down correctly. Many teachers will choose to Frequent bouts of tears and low self-esteem. that they won’t be able to do anything initial an assignment notebook to indicate that information Fear of new situations right. Their fears of being embarrassed, is correct. Drug or alcohol abuse As many as 1 in 10 young people suffer from an AD. About 50% with humiliated, or failing may result in Consider modifying or adapting the curriculum to better AD also have a second AD or other behavioral disorder (e.g. school avoidance. Getting behind in their suit the student’s learning style-this may lessen his/her depression). -
A Dictionary of Neurological Signs
FM.qxd 9/28/05 11:10 PM Page i A DICTIONARY OF NEUROLOGICAL SIGNS SECOND EDITION FM.qxd 9/28/05 11:10 PM Page iii A DICTIONARY OF NEUROLOGICAL SIGNS SECOND EDITION A.J. LARNER MA, MD, MRCP(UK), DHMSA Consultant Neurologist Walton Centre for Neurology and Neurosurgery, Liverpool Honorary Lecturer in Neuroscience, University of Liverpool Society of Apothecaries’ Honorary Lecturer in the History of Medicine, University of Liverpool Liverpool, U.K. FM.qxd 9/28/05 11:10 PM Page iv A.J. Larner, MA, MD, MRCP(UK), DHMSA Walton Centre for Neurology and Neurosurgery Liverpool, UK Library of Congress Control Number: 2005927413 ISBN-10: 0-387-26214-8 ISBN-13: 978-0387-26214-7 Printed on acid-free paper. © 2006, 2001 Springer Science+Business Media, Inc. All rights reserved. This work may not be translated or copied in whole or in part without the written permission of the publisher (Springer Science+Business Media, Inc., 233 Spring Street, New York, NY 10013, USA), except for brief excerpts in connection with reviews or scholarly analysis. Use in connection with any form of information storage and retrieval, electronic adaptation, computer software, or by similar or dis- similar methodology now known or hereafter developed is forbidden. The use in this publication of trade names, trademarks, service marks, and similar terms, even if they are not identified as such, is not to be taken as an expression of opinion as to whether or not they are subject to propri- etary rights. While the advice and information in this book are believed to be true and accurate at the date of going to press, neither the authors nor the editors nor the publisher can accept any legal responsibility for any errors or omis- sions that may be made. -
ABILIFY (Aripiprazole)
1 Rx only ® 2 ABILIFY (aripiprazole) 3 ABILIFY® (aripiprazole) Tablets 4 ABILIFY® DISCMELT™ (aripiprazole) Orally Disintegrating Tablets 5 ABILIFY® (aripiprazole) Oral Solution ® 6 ABILIFY (aripiprazole) Injection FOR INTRAMUSCULAR USE ONLY 7 8 WARNING 9 Increased Mortality in Elderly Patients with Dementia-Related 10 Psychosis 11 Elderly patients with dementia-related psychosis treated with atypical antipsychotic 12 drugs are at an increased risk of death compared to placebo. Analyses of seventeen 13 placebo-controlled trials (modal duration of 10 weeks) in these patients revealed a 14 risk of death in the drug-treated patients of between 1.6 to 1.7 times that seen in 15 placebo-treated patients. Over the course of a typical 10-week controlled trial, the 16 rate of death in drug-treated patients was about 4.5%, compared to a rate of about 17 2.6% in the placebo group. Although the causes of death were varied, most of the 18 deaths appeared to be either cardiovascular (eg, heart failure, sudden death) or 19 infectious (eg, pneumonia) in nature. ABILIFY is not approved for the treatment of 20 patients with dementia-related psychosis. 21 DESCRIPTION ® 22 Aripiprazole is a psychotropic drug that is available as ABILIFY (aripiprazole) tablets, ® ® 23 ABILIFY DISCMELT™ (aripiprazole) orally disintegrating tablets, ABILIFY ® 24 (aripiprazole) oral solution, and ABILIFY (aripiprazole) injection, a solution for 25 intramuscular injection. Aripiprazole is 7-[4-[4-(2,3-dichlorophenyl)-1- 26 piperazinyl]butoxy]-3,4-dihydrocarbostyril. The empirical formula is C23H27Cl2N3O2 and 27 its molecular weight is 448.39. 1 of 53 Approved 1.0 Item 2 current.pdf 28 The chemical structure is: Cl Cl N N CH2CH2CH2CH2O N O H 29 30 ABILIFY tablets are available in 2-mg, 5-mg, 10-mg, 15-mg, 20-mg, and 30-mg 31 strengths. -
Schizoaffective Disorder?
WHAT IS SCHIZOAFFECTIVE DISORDER? BASIC FACTS • SYMPTOMS • FAMILIES • TREATMENTS RT P SE A Mental Illness Research, Education and Clinical Center E C I D F I A C VA Desert Pacific Healthcare Network V M R E E Long Beach VA Healthcare System N T T N A E L C IL L LN A E IC S IN Education and Dissemination Unit 06/116A S R CL ESE N & ARCH, EDUCATIO 5901 E. 7th street | Long Beach, CA 90822 basic facts Schizoaffective disorder is a chronic and treatable psychiatric Causes illness. It is characterized by a combination of 1) psychotic symp- There is no simple answer to what causes schizoaffective dis- toms, such as those seen in schizophrenia and 2) mood symptoms, order because several factors play a part in the onset of the dis- such as those seen in depression or bipolar disorder. It is a psychi- order. These include a genetic or family history of schizoaffective atric disorder that can affect a person’s thinking, emotions, and be- disorder, schizophrenia, or bipolar disorder, biological factors, en- haviors and can impact all aspects of daily living, including work, vironmental stressors, and stressful life events. school, social relationships, and self-care. Research shows that the risk of schizoaffective disorder re- Schizoaffective disorder is considered a psychotic disorder sults from the influence of genes acting together with biological because of its prominent features of hallucinations and delusions. and environmental factors. A family history of schizoaffective dis- Therefore, people with this illness have periods when they have order does not necessarily mean children or other relatives will difficulty understanding the reality around them. -
Racing and Crowded Thoughts in Mood Disorders: a Data-Oriented Theoretical Reappraisal Gilles Bertschy, Sebastien Weibel, Anne Giersch, Luisa Weiner
Racing and crowded thoughts in mood disorders: A data-oriented theoretical reappraisal Gilles Bertschy, Sebastien Weibel, Anne Giersch, Luisa Weiner To cite this version: Gilles Bertschy, Sebastien Weibel, Anne Giersch, Luisa Weiner. Racing and crowded thoughts in mood disorders: A data-oriented theoretical reappraisal. L’Encéphale, Elsevier Masson, 2020, 46 (3), pp.202-208. 10.1016/j.encep.2020.01.007. hal-02935003 HAL Id: hal-02935003 https://hal.archives-ouvertes.fr/hal-02935003 Submitted on 15 Sep 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Review of the literature Racing and crowded thoughts in mood disorders: A data-oriented theoretical reappraisal Tachypsychie dans les troubles de l’humeur : une réévaluation théorique basée sur les données de la littérature a,b,c, a,b b a,d,e G. Bertschy ∗ , S. Weibel , A. Giersch , L. Weiner a Pôle de psychiatrie, santé mentale & addictologie des hôpitaux universitaires de Strasbourg, 67000 Strasbourg, France b Inserm U1114, 67000 Strasbourg, France c Fédération de médecine translationnelle de Strasbourg, université de Strasbourg, 67000 Strasbourg, France d Laboratoire de psychologie des cognitions, 67000 Strasbourg, France e Faculté de psychologie, université de Strasbourg, 67000 Strasbourg, France a r t i c l e i n f o a b s t r a c t Article history: Objectives. -
Racing Thoughts: What to Consider
Pearlsearls Racing thoughts: What to consider Theodore J. Wilf, MD Dr. Wilf is a Consultant Psychiatrist, Table Warren E. Smith Health Centers, ave you ever had times in Philadelphia, Pennsylvania. your life when you had a tremen- Causes of racing thoughts Disclosure dous amount of energy, like too Medications and illicit drugs The author reports no financial H much energy, with racing thoughts? relationships with any companies Amphetamines whose products are mentioned in I initially ask patients this question Methylphenidate this article, or with manufacturers when evaluating for bipolar disorder. Dexamethasone of competing products. Cocaine Some patients insist that they have rac- Phencyclidine ing thoughts—thoughts occurring at a Medical disorders rate faster than they can be expressed 1 Stroke through speech —but not episodes of Traumatic brain injury hyperactivity. This response suggests Multiple sclerosis that some patients can have racing Cushing’s disease thoughts without a diagnosis of bipolar Source: Reference 1 disorder. Among the patients I treat, racing thoughts vary in severity, duration, and Other potential causes treatment. When untreated, a patient’s Racing thoughts are a symptom, not a racing thoughts may range from a mild diagnosis. Apprehension and anxiety disturbance lasting a few days to a more could cause racing thoughts that do not severe disturbance occurring daily. In this require treatment with a mood stabilizer article, I suggest treatments that may help or antipsychotic. Patients who often worry ameliorate racing thoughts, and describe about having panic attacks or experience possible causes that include, but are not severe chronic stress may have racing limited to, mood disorders. -
The Implications of Hypersomnia in the Context of Major Depression: Results from a Large, International, Observational Study
European Neuropsychopharmacology (2019) 29, 471–481 www.elsevier.com/locate/euroneuro The implications of hypersomnia in the context of major depression: Results from a large, international, observational study a a, b c a A. Murru , G. Guiso , M. Barbuti , G. Anmella , a, d ,e a ,f , g g h N. Verdolini , L. Samalin , J.M. Azorin , J. Jules Angst , i j k a, l C.L. Bowden , S. Mosolov , A.H. Young , D. Popovic , m c a, ∗ a M. Valdes , G. Perugi , E. Vieta , I. Pacchiarotti , For the BRIDGE-II-Mix Study Group a Barcelona Bipolar and Depressive Disorders Unit, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain b Clinica Psichiatrica, Dipartimento di Igiene e Sanità, Università di Cagliari, Italy c Division of Psychiatry, Clinical Psychology and Rehabilitation, Department of Medicine, University of Perugia, Santa Maria della Misericordia Hospital, Edificio Ellisse, 8 Piano, Sant’Andrea delle Fratte, 06132, Perugia, Italy d FIDMAG Germanes Hospitalàries Research Foundation, Sant Boi de Llobregat, Barcelona, Catalonia, Spain e Division of Psychiatry, Clinical Psychology and Rehabilitation, Department of Medicine, Santa Maria della Misericordia Hospital, University of Perugia, Perugia, Italy f CHU Clermont-Ferrand, Department of Psychiatry, University of Auvergne, Clermont-Ferrand, France g Fondation FondaMental, Hôpital Albert Chenevier, Pôle de Psychiatrie, Créteil, France h Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich, -
SPEECH DISORDERS Amr Hassan, MD,FEBN Associate Professor of Neurology Cairo University
NOTE: To change the image on this slide, select the picture and delete it. Then click the Pictures icon in the placeholde r to insert your own image. SPEECH DISORDERS Amr Hassan, MD,FEBN Associate professor of Neurology Cairo University Definition of Speech Speech is the communication of meanings by means of symbols, which usually take the form of spoken or written words. Mechanisms of Speech : 1. Central Mechanisms: Depending on the integration of the higher brain centers for symbolization (speech centers), mainly in the dominant hemisphere. Lesion leads to Dysphasia or Aphasia. 2. Peripheral Mechanisms: A. Articulation: Lesion leads to Dysarthria or Anarthria. B. Phonation: Lesion leads to Dysphonia or Aphonia. Aphonia . Phonation is lost but articulation is preserved . The patient talks in whisper Types and Causes: A. Hysterical (can phonate when coughing) B. Organic 1. Bilateral paralysis of the vocal cords 2. Diseases of larynx 3. Paresis of respiratory movements 4. Spastic dysphonia 5. Glottis spasm Dysarthria Dysarthria=Disorder of articulation Types and Causes: 1. LMN Dysarthria 2. UMN (spastic) Dysarthria 3. Extra-pyramidal Dysarthria a. Rigid dysarthria: Parkinsonism b. Hiccup speech: Chorea and myoclonus 4. Cerebellar Dysarthria a. Syllabic (or scanning) b. Explosive c. Stacatto Mechanisms of Speech : 1. Central Mechanisms: Depending on the integration of the higher brain centers for symbolization (speech centers), mainly in the dominant hemisphere. Lesion leads to Dysphasia or Aphasia. 2. Peripheral Mechanisms: A. Articulation: Lesion leads to Dysarthria or Anarthria. B. Phonation: Lesion leads to Dysphonia or Aphonia. Speech Centers I. Sensory Centers: A. Visual Centers: Area 17 for visual reception.